A joint venture has sold a two-building, 304,000-square-foot office complex in Paramus after acquiring it in 2016 and completing more than $3 million worth of upgrades.
Teva Pharmaceuticals isn’t the only life sciences company to impact New Jersey’s office market this year, as several others have inked sizable leases to expand or upgrade their space.
